The purpose of this study is to compare the efficacy of buccal misoprostol cervical priming to laminaria priming among women undergoing D\&E at 13-20 weeks gestation in the Western Cape Province, South Africa
As misoprostol is increasingly being used for cervical preparation, concerns about its use and about the proportion of women expelling the fetus prior to the D\&E and other side effects mean that rigorous data on possible advantages of osmotic dilators are needed. To address this gap in the literature, we propose to perform an RCT comparing two methods of cervical preparation prior to D\&E: 1. Misoprostol 400 mcg administered buccally approximately 3-6 hours prior to D\&E, repeated once 3 hours after the first dose (a modified version of the current protocol) 2. Laminaria tents inserted into the cervix 18 to 24 hours prior to D\&E
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
159
Misoprostol 400 mcg administered buccally approximately 3-6 hours prior to D\&E, repeated once 3 hours after the first dose if needed
Laminaria tents inserted into the cervix 18 to 24 hours prior to D\&E
Tygerberg Hospital
Cape Town, South Africa
Proportion of women with fetal expulsion prior to dilation and evacuation
Time frame: Prior to D&E procedure
Proportion of women requiring additional dilation (manual or pharmacologic)
Time frame: At time of D&E procedure
Duration of dilation and evacuation procedure
Time frame: End of D&E procedure
Frequency of major complications
Major complications to include: * Death * Admission to the ward after the procedure * Readmission after discharge * Abdominal surgical procedure * Suspected uterine perforation * Seizure * Hemorrhage requiring transfusion * Loss to follow-up after placement of laminaria
Time frame: Recorded at TOP visit and/or follow-up visit (target 7 days after procedure)
Frequency of Minor Complications
Minor complications to include: * Hemorrhage not requiring transfusion * Infection requiring outpatient treatment * Trauma to cervix or vagina * Transfer to another facility to complete the procedure * Need for repeat surgical evacuation of the uterus
Time frame: Recorded at TOP visit and/or follow-up visit (target 7 days after procedure)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.